BAJAJ BROKING
Tata Chemicals reported a significant reduction in consolidated net loss for Q4 FY25 at Rs.56 crore, compared to a steep Rs.850 crore loss in the same period last year. Despite continued pricing pressures across geographies, revenue grew marginally by 1% year-on-year (YoY) to Rs.3,509 crore. The company’s EBITDA declined 26% YoY to Rs.327 crore, with margins contracting to 9.3% from 13.8%, primarily due to rising costs.
Q4 Net Loss: Rs.56 crore, narrowed from Rs.850 crore YoY
Q4 Revenue: Rs.3,509 crore, up 1% YoY
EBITDA: Rs.327 crore vs Rs.443 crore YoY, down 26%
EBITDA Margin: 9.3% vs 13.8% YoY
Dividend: Rs.11 per equity share (110%), subject to approval
Fundraising Plan: Up to Rs.200 crore via term loans/NCDs
Tata Chemicals Share Price: Rose 2.2% to Rs.844.3 post-results
The sharp decline in net loss reflects a notable improvement in operational efficiency and cost control. However, global pricing challenges and elevated input costs weighed on profitability. Revenue saw marginal growth amid stabilising demand, particularly in India, though key international markets like the US, China, and Western Europe remained under pressure.
The board has recommended a dividend of Rs.11 per share for FY25, payable post-AGM approval. Additionally, the company will raise up to Rs.200 crore through private placement of term loans or non-convertible debentures (NCDs).
India Operations: Steady growth despite input cost pressure.
International Markets: Softness observed in US, Europe, and China.
New Funding: Will support liquidity and business continuity.
Sustainability Outlook: Remains positive over medium to long term.
Metric | Q4 FY24-25 | Q4 FY23-24 | YoY Change |
Net Profit (Loss) | Rs.56 crore | Rs.850 crore loss | — |
Revenue | Rs.3,509 crore | Rs.3,475 crore | +1.0% |
EBITDA | Rs.327 crore | Rs.443 crore | -26.2% |
EBITDA Margin | 9.3% | 13.8% | -450 bps |
Dividend | Rs.11/share | — | — |
For a full summary of market-moving earnings and upcoming reports, explore our Quarterly Results Calendar 2025.
Source: Tata Chemicals – Board Meeting Outcome and Audited Q4 FY25 Results (8 May 2025).
Share this article:
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading